IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q2 2020 Holdings

Filed 2020-08-14 | 19 holdings | $3.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aldeyra Therapeutics Inc(ALDX)COM01438T106$2.4M569,40570.8%
Corteva Inc(CTVA)COM22052L104$811.0K30,00024.2%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$62.1K857,4941.9%
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$42.3K5,045,8701.3%
Applied Therapeutics Inc(APLT)COM03828A101$23.0K650,2380.7%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$8.2K2,859,7670.2%
Orgenesis, Inc.COM68619K105$8.0K1,316,3640.2%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$5.1K525,2380.2%
Anavex Life Sciences Corp(AVXL)COM NEW032797300$3.6K724,2050.1%
Exicure Inc(XCUR)COM30205M101$3.1K1,277,7770.1%
Entera Bio Ltd(ENTX)SHSM40527109$3.0K1,741,3630.1%
Blackstone Group LP(BXUSD)COM UNIT LTD09253U108$2.2K40,0000.1%
Centurylink Inc(CTLEUR)COM156700106$2.2K220,0000.1%
Soligenix Inc.COM834223307$1.6K787,8300.0%
Molecular TemplatesCOM608550109$1.5K113,9050.0%
Dow Inc(DOW)COM260557103$1.2K30,0000.0%
Catasys IncCOM PAR149049504$1.1K43,0340.0%
BioXCel Therapeutics Inc(BTAIEUR)COM09075P105$1.1K20,0000.0%
Dupont de Nemours Inc(DD)COM26614N102$78515,0000.0%